Expanding Market Application NEXGEL's trans-dermal delivery system, originally FDA-approved for hospital wound care, has successfully expanded into consumer OTC, prescription, medical device, and cosmetic markets. This diverse application base indicates significant sales potential across multiple healthcare and consumer segments, presenting opportunities to tailor marketing and sales strategies for each niche.

Recent Funding & Growth The company secured nearly $2.8 million through recent financings and planned acquisitions, demonstrating strong investor confidence and financial momentum. This capital infusion supports expansion efforts, new product development, and increased outreach to healthcare providers and consumer markets, opening avenues for strategic partnerships and upsell opportunities.

Active Industry Engagement Participation in high-profile investor events such as LD Micro Main Event, Planet MicroCap Showcase, and virtual conferences highlights NEXGEL's efforts to raise its profile and attract new investors and partners. Sales teams can leverage these engagements by identifying potential collaborations and expanding their network within the investor community.

Leadership & Strategic Focus The appointment of experienced leadership, including new board members and CFO, indicates a strategic focus on strengthening corporate governance and operational efficiency. This leadership stability and strategic direction can instill confidence in potential customers and partners, easing negotiations and fostering long-term sales relationships.

SMB Market Positioning With a small team of 2-10 employees but serving a revenue range of up to $10 million, NEXGEL is positioned as a nimble player capable of quick innovation and customized solutions. This agility makes it an attractive partner for large healthcare companies seeking innovative, FDA-approved hydrogel products to enhance their offering and for niche markets looking for specialized transdermal formulations.